A Trial of Lopinavir-Ritonavir in Covid-19. Reply
N Engl J Med
.
2020 May 21;382(21):e68.
doi: 10.1056/NEJMc2008043.
Epub 2020 May 5.
Authors
Bin Cao
1
,
Dingyu Zhang
2
,
Chen Wang
3
Affiliations
1
China-Japan Friendship Hospital, Beijing, China caobin_ben@163.com.
2
Jin Yin-tan Hospital, Wuhan, China.
3
China-Japan Friendship Hospital, Beijing, China.
PMID:
32369286
DOI:
10.1056/NEJMc2008043
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Humans
Lopinavir
Pandemics
Pneumonia, Viral*
Ritonavir*
SARS-CoV-2
Substances
Lopinavir
Ritonavir